Panel votes to recommend FDA approve Pfizer vaccine for emergency use

An independent advisory panel voted on Thursday in favor of recommending that the U.S. Food and Drug Administration authorize the Pfizer-BioNTech COVID-19 vaccine for emergency use, Stat News reports.
The 17-4 vote came after a lengthy meeting in which the panel of experts discussed whether the benefits of the vaccine candidate outweighed the risks for patients age 16 and up, reports NBC News. The vote was a key step on the path to FDA approval — while the FDA isn't obligated to follow the panel's recommendation, it is widely expected to authorize the vaccine and allow for the nation's existing doses to be distributed to priority groups, namely health care workers and long-term care facility residents. The Pfizer vaccine has already been approved for use in the U.K., Saudi Arabia, Canada and Bahrain. Read more at Stat News and NBC News.
Subscribe to The Week
Escape your echo chamber. Get the facts behind the news, plus analysis from multiple perspectives.

Sign up for The Week's Free Newsletters
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
From our morning news briefing to a weekly Good News Newsletter, get the best of The Week delivered directly to your inbox.
Sign up for Today's Best Articles in your inbox
A free daily email with the biggest news stories of the day – and the best features from TheWeek.com
-
A running list of all the celebrities Trump has pardoned
IN DEPTH Reality stars, rappers and disgraced politicians have received some of the high-profile pardons doled out by the president
-
US credit rating: what it is and why it matters
the explainer Credit rating agency Moody's downgraded the US last month
-
Nationalist wins tight Polish presidential election
speed read Karol Nawrocki beat Rafal Trzaskowski in Poland's presidential runoff election
-
RFK Jr. scraps Covid shots for pregnant women, kids
Speed Read The Health Secretary announced a policy change without informing CDC officials
-
New FDA chiefs limit Covid-19 shots to elderly, sick
speed read The FDA set stricter approval standards for booster shots
-
US overdose deaths plunged 27% last year
speed read Drug overdose still 'remains the leading cause of death for Americans aged 18-44,' said the CDC
-
Trump seeks to cut drug prices via executive order
speed read The president's order tells pharmaceutical companies to lower prescription drug prices, but it will likely be thrown out by the courts
-
RFK Jr. visits Texas as 2nd child dies from measles
Speed Read An outbreak of the vaccine-preventable disease continues to grow following a decade of no recorded US measles deaths
-
Shingles vaccine cuts dementia risk, study finds
Speed Read Getting vaccinated appears to significantly reduce the chances of developing Alzheimer's and other forms of dementia
-
Measles outbreak spreads, as does RFK Jr.'s influence
Speed Read The outbreak centered in Texas has grown to at least three states and Health Secretary Robert F. Kennedy Jr. is promoting unproven treatments
-
RFK Jr. offers alternative remedies as measles spreads
Speed Read Health secretary Robert F. Kennedy Jr. makes unsupported claims about containing the spread as vaccine skepticism grows